You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Contact Allergens in Oral Antihistamines

McEnery-Stonelake, Melissa BA*; Silvestri, Dianne L. MD

Dermatitis:
doi: 10.1097/DER.0000000000000028
Studies
Abstract

Background: Excipients in various formulations of active drugs occasionally include known contact allergens. Their ingestion may trigger dermatitis or cause it to become widespread or refractory to therapy.

Objective: The aim of this study was to investigate the prevalence of common contact allergens among the excipients of oral antihistamines available in this country.

Methods: We gathered the complete ingredient lists of 2119 different preparations of 12 oral antihistamines from the National Library of Medicine data bank and entered them into an electronic database for analysis.

Results: More than half the formulations (55.0%) contained at least 1 member of the 10 allergen families assessed. Most brompheniramine and doxepin preparations included potentially allergenic excipients, whereas fexofenadine was most often free of them. Sorbitan group members, azo dyes, and propylene glycol were the allergens found most frequently in the antihistamines, each present in over 25% of the products. Elixirs, liquids, solutions, suspensions, and syrups were more likely than nonchewable caplets, capsules, and tablets to contain the allergens tabulated (100% vs 39.3%, respectively). Chewable pills frequently contained azo dyes.

Conclusions: Ingestion of antihistamines could precipitate a systemic contact dermatitis in a patient sensitized to an allergen present as an excipient in the medicine.

Author Information

From the *University of Massachusetts Medical School; and †UMass Memorial Medical Center, Worcester, MA.

Address reprint requests to Dianne L. Silvestri, MD, Division of Dermatology, UMass Memorial Medical Center, 281 Lincoln St, Worcester, MA. E-mail: dianne.silvestri@gmail.com.

The authors have no funding or conflicts of interest to declare.

© 2014 American Contact Dermatitis Society

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.